YURIYA-PHARM

Kyiv, Ukraine Founded: 1990 • Age: 36 yrs
An RD-focused company manufacturing drugs for various therapeutic areas.

About YURIYA-PHARM

YURIYA-PHARM is a company based in Kyiv (Ukraine) founded in 1990. It operates as a B2B. YURIYA-PHARM has completed 1 acquisition, including REKA-MED. YURIYA-PHARM operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.

  • Headquarter Kyiv, Ukraine
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of YURIYA-PHARM
Headcount 1000-5000
Employee Profiles 22
Employee Profiles
People
Anna Solodovnyk
Business Development Manager
People
Daria Topchiienko
Senior Business Development Manager
People
Olesia Paliichuk
Business Development Manager
People
Vitalina Nikitina
Head Of Business Development

Unlock access to complete

Funding Insights of YURIYA-PHARM

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by YURIYA-PHARM

YURIYA-PHARM has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include REKA-MED. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Infusion intravenous preparations and injectable solutions are manufactured.
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - YURIYA-PHARM

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Yuriya-Pharm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of YURIYA-PHARM

YURIYA-PHARM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical products are manufactured and marketed worldwide.
domain founded_year HQ Location
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
domain founded_year HQ Location
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
domain founded_year HQ Location
Traditional pharmaceutical medicines are developed for multiple health fields.
domain founded_year HQ Location
Developer of drugs for the treatment of multiple disorders
domain founded_year HQ Location
Biopharmaceutical research and drug development are conducted globally by AbbVie.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Yuriya-Pharm

Frequently Asked Questions about YURIYA-PHARM

When was YURIYA-PHARM founded?

YURIYA-PHARM was founded in 1990.

Where is YURIYA-PHARM located?

YURIYA-PHARM is headquartered in Kyiv, Ukraine.

What does YURIYA-PHARM do?

YURIYA-PHARM an rd-focused company manufacturing drugs for various therapeutic areas through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and rd. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of YURIYA-PHARM?

YURIYA-PHARM's top competitors include Merck, Roivant Sciences and AbbVie.

How many acquisitions has YURIYA-PHARM made?

YURIYA-PHARM has made 1 acquisition, including REKA-MED.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available